AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Ekso Bionics shares jump 10.18% premarket after securing exclusive U.S. distribution deal for MediTouch's BalanceTutor rehabilitation system.
ByAinvest
Thursday, Dec 4, 2025 8:00 am ET1min read
Ekso Bionics surged 10.18% in premarket trading following the announcement of an exclusive U.S. distribution agreement with MediTouch for the BalanceTutor rehabilitation system. The deal grants Ekso Bionics rights to distribute a patented 4D perturbation treadmill system designed to improve patient balance through simulated real-world disturbances. The company emphasized strategic alignment with its existing enterprise health solutions, leveraging shared customer touchpoints to expand market reach. MediTouch highlighted the partnership as a milestone to broaden access to its technology. The partnership is positioned to enhance Ekso Bionics’ offerings in medical rehabilitation, reinforcing its growth narrative amid a $11.5 million market capitalization.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet